Globus Medical Sees EPS Estimate Rise to $4.28 and 8% Revenue Growth
Globus Medical’s current-year earnings consensus climbed by $0.27 to $4.28 per share, with revenues forecast at $3.2 billion, marking 8% year-over-year growth. Shares have surged since November on renewed momentum in its robotics division and robust demand in the U.S. spine segment.
1. Consensus Estimates Rise
Analysts have lifted Globus Medical’s current-year earnings forecast by $0.27 to $4.28 per share and project $3.2 billion in revenues, reflecting an 8% increase from the prior year.
2. Robotics and Spine Segment Strength
Since November, the robotics division has regained traction through new product rollouts, while the U.S. spine segment experienced strong order growth, driving overall share performance.
3. Strong Buy Rating
Globus Medical holds a top-tier Strong Buy analyst rating, reinforcing investor confidence as the company capitalizes on its robotics and spine market leadership.